Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion

Oncology Reports

Volumn 24, Issue 3, 2010, Pages 599-606

  Nakayama, Toshiyuki ^a   Hirakawa, Hiroshi ^a   Shibata, Kenichiro ^a   Abe, Kuniko ^a   Nagayasu, Takeshi ^a   Taguchi, Takashi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Angiopoietin like 4; Human gastric cancer; Immunohistochemistry; Venous invasion

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; MESSENGER RNA; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; ENDOSCOPIC MUCOSAL RESECTION; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; MUCINOUS CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; TUMOR DIFFERENTIATION; TUMOR GROWTH; UNIVARIATE ANALYSIS; WESTERN BLOTTING;

ADENOCARCINOMA; ANGIOPOIETINS; BLOTTING, WESTERN; CELL LINE, TUMOR; GASTRECTOMY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VEINS;

EID: 77956306581     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000897     Document Type: Article

References (48)

1. Neugut AI, Hayek M and Howe G: Epidemiology of gastric cancer. Semin Oncol 23: 281-291, 1996.
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. New Engl J Med 319: 525-532, 1988.
3. Ming SC: Pathology of the gastrointestinal tract. 2nd edition. Ming SC and Goldman H (eds). Williams & Wilkins, Baltimore, pp632-633, 1998.
4. Goseki N, Koike M and Yoshida M: Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 69: 1088-1093, 1992.
5. Fidler IJ: Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol 43 (Suppl.): S3-S10, 1999.
6. Fidler IJ: Critical determinants of human colon cancer metastasis. In: Molecular Pathology of Gastroenterological Cancer. Tahara E (ed). Springer-Verlag, Berlin, pp147-169, 1997.
7. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M and Nakayama H: Molecular-pathological prognostic factors of gastric cancer. Gastric Cancer 8: 86-94, 2005.
8. Nakayama T, Hatachi G, Wen CY, Yoshizaki A, Yamazumi K, Niino D and Sekine I: Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: immunohistochemical analysis and correlation with clinicopathological factors. World J Gastroenterol 11: 964-969, 2005. (Pubitemid 40347746)
9. Nakayama T, Yoshizaki A, Kawahara N, Ohtsuru A, Wen CY, Fukuda E, Nakashima M and Sekine I: Expression of Tie-1 and 2 receptors, and angiopoietin-1, 2 and 4 in gastric carcinoma; immunohistochemical analyses and correlation with clinicopathological factors. Histopathology 44: 232-239, 2004.
10. Bach F, Uddin FJ and Burke D: Angiopoietins in malignancy. Eur J Surg Oncol 33: 7-15, 2007.
11. Yu X, Burgess SC, Ge H, Wong KK, Wong KK, Nassem RH, Garry DJ, Sherry AD, Malloy CR, Berger JP and Li C: Inhibition of cardiac lipoprotein utilization by transgenic overexpression of ANGPTL4 in the heart. Proc Natl Acad Sci USA 102: 1767-1772, 2005.
12. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Müller M and Kersten S: The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281: 934-944, 2006.
13. Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, Hobbs HH and Cohen JC: Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39: 513-516, 2007. (Pubitemid 46514768)
14. Ge H, Yang G, Huang L, Motola DL, Pourbahrami T and Li C: Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J Biol Chem 279: 2038-2045, 2004. (Pubitemid 38084475)
15. Le Jan S, Amy C, Cazes A, Monnot C, Lamandé N, Favier J, Philippe J, Sibony M, Gasc JM, Corvol P and Germain S: Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 162: 1521-1528, 2003.
16. Yoshida K, Shimizugawa T, Ono M and Furukawa H: Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43: 1770-1772, 2002.
17. Xu A, Lam MC, Chan KW, Wang Y, Zhang J, Hoo RL, Xu JY, Chen B, Chow WS, Tso AW and Lam KS: Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci USA 102: 6086-6091, 2005.
18. Oike Y, Yasunaga K and Suda T: Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. Int J Hematol 80: 21-28, 2004.
19. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR and Massagué J: TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77, 2008. (Pubitemid 351442989)
20. Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E, Mekid H, Mir LM, Opolon P, Corvol P, Monnot C and Germain S: Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 103: 18721-18726, 2006.
21. Girroir EE, Hollingshead HE, Billin AN, Willson TM, Robertson GP, Sharma AK, Amin S, Gonzalez FJ and Peters JM: Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology 243: 236-243, 2008.
22. Japanese Research Society for Gastric Cancer: Japanese classification of gastric cancer. Kanehara Press, Tokyo, 1995.
23. Watanabe H, Jass JR and Sabin LH: Histological typing of oesophageal and gastric tumors. World Health Organization International Histological Classification of Tumors. Springer, Berlin, pp20-26, 1989.
24. Sobin LH and Wittekind CH (eds): International Union Against Cancer. TNM classification of malignant tumors. 5th edition. John Wiley & Sons, Inc., New York, 1997.
25. Jass JR, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM and Todd IP: The grading of rectal cancer: histological perspective and a multivariate analysis of 447 cases. Histopathology 10: 437-459, 1986. (Pubitemid 16039125)
26. Seefeld PH and Bargen JA: The spread of cancer of the rectum: invasion of the lymphatics, veins and nerves. Ann Surg 118: 76-89, 1943.
27. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJ and Morson BC: Invasion of veins by carcinoma of rectum: methods of detection, histological features and significance. Histopathology 5: 141-163, 1981.
28. Nakayama T, Yoshizaki A, Izumida S, Suehiro T, Miura S, Uemura T, Yakata Y, Shichijo K, Yamashita S and Sekin I: Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int J Oncol 30: 825-833, 2007.
29. Van Dekken H, Pizzolo JG, Kelsen DP and Melamed MR: Targeted cytogenetic analysis of gastric tumors by in situ hybridization with a set of chromosome-specific DNA probes. Cancer 66: 491-497, 1990. (Pubitemid 20233446)
30. McSherry EA, Donatello S, Hopkins AM and McDonnell S: Molecular basis of invasion in breast cancer. Cell Mol Life Sci 64: 3201-3218, 2007.
31. Bierie B and Moses HL: Tumour microenvironment: TGFbeta - the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520, 2006.
32. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC and Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169, 1996.
33. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD and Isner J: Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273: 18514-18521, 1998. (Pubitemid 28334780)
34. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN and Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60, 1997.
35. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN and Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87: 1171-1180, 1996.
36. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W and Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74, 1995.
37. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H, McClain J, Copeland NG, Gilbert DJ, Jenkins NA, Huang T, Papadopoulos N, Maisonpierre PC, Davis S and Yancopoulos GD: Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96: 1904-1909, 1999.
38. Kawai Y, Minami T, Fujimori M, Hosaka K, Mizuno R, Ikomi F, Kodama T and Ohhashi T: Characterization and microarray analysis of genes in human lymphatic endothelial cells from patients with breast cancer. Lymphat Res Biol 5: 115-126, 2007.
39. Li KQ, Li WL, Peng SY, Shi XY, Tang HL and Liu YB: Antitumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection. Chin Med J (Engl) 117: 1364-1369, 2004.
40. Ifon ET, Pang AL, Johnson W, Cashman K, Zimmerman S, Muralidhar S, Chan WY, Casey J and Rosenthal LJ: U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. Cancer Cell Int 5: 19, 2005.
41. Lewis CE, De Palma M and Naldini L: Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res 67: 8429-8432, 2007. (Pubitemid 47437413)
42. Crissman JD, Hatfield JS, Menter DG, Sloane B and Honn KV: Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 48: 4065-4072, 1988.
43. Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002.
44. Carmeliet P: Angiogenesis in health and disease. Nat Med 9: 653-660, 2003.
45. Achen MG, McColl BK and Stacker SA: Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7: 121-127, 2005.
46. Cazes A, Galaup A, Chomel C, Bignon M, Bréchot N, Le Jan S, Weber H, Corvol P, Muller L, Germain S and Monnot C: Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration and sprouting and alters actin cytoskeleton. Circ Res 99: 1207-1215, 2006.
47. Halvorsen TB and Seim E: Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol 42: 162-166, 1989.
48. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S and Sekine I: Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 13: 925-933, 2000.